Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,182.1
0.8 (0.03%)

 

  • STI Straits Times Index
    3,182.1
    0.8 (0.03%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,549.0
    -2.6 (-0.17%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    27,160.3
    -780.2 (-2.79%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,976.5
    -84.2 (-2.75%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,379.4
    163.7 (0.71%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,120.3
    9.2 (0.15%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,185.3
    8.6 (0.39%)
    Index delayed 20 minutes
  • XAO XAO
    7,135.9
    37.5 (0.53%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 973.1M
  • Value: 571.5M
  • Rise: 182
  • Fall: 126
  • Unch: 508

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Medtecs Intl0.199+0.027
Healthway Med0.044-0.002
AsiaMedic0.017-
UG Healthcare0.395+0.145
Golden Agri-Res0.220-0.005
MarcoPolo Marine0.022+0.001
Rex Intl0.176+0.008
Thomson Medical0.064+0.001
Ntegrator Intl0.011-
Jiutian Chemical0.018+0.002

World Indices

World Indices
Name Last Change
Nasdaq 9,269.7 +130.4
HSI 27,156.3 -784.2
HSCEI 10,595.7 -373.6
Jakarta 6,116.8 +5.6
Nikkei 225 23,379.4 +163.7
SSE Comp 2,976.5 -84.2
Shanghai A 3,118.9 -88.2
Shanghai B 248.6 -8.9
PSE Comp 0.0
KOSPI 2,185.3 +8.6

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ORAGENICS INC ORAGENICS INC
Updated on 28 Jan 2020 (End of trading day)
Last (USD): 0.434 Change: -0.002 High: 0.456 Remarks: -
Change (%): -0.44 Low: 0.430
Open 0.440 Yesterday's Close 0.43570000000000003
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 254,682 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.22986 Trailing EPS (USD) e -0.29883 NAV (USD) b 0.2903
PE a - Trailing PE f - Price / NAV b 1.4943
Dividend (USD) d - Cash In Hand (USD) g 0.4524 Issued & Paid-up Shares c 46,125,000
Dividend Yield (%) d - Price / Cash In Hand g 0.959 Treasury Shares h -
Beta - 75 Daysi 0.690 R-Squared - 75 Days(%)i 1.09 Market Cap (M) 21.375
Beta - 500 Daysi 1.171 R-Squared - 500 Days (%)i 0.07 Enterprise Value (M) 6.535
Piotroski F Score 2 Exchange Code OGEN Par Value ( $ ) n.a.
52 Weeks Volatility (%) 66.89 Free Float (%) 90.8
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 14 May 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 29 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ORAGENICS INC NYSE American 21.375 - - 1.4943 -
Industry Biotechnology NYSE American 107.985 - - 4.1036 -
Local Peer NANOVIRICIDES INC NYSE American 529.805 - - 58.0511 -
Local Peer PFENEX INC NYSE American 262.819 - - 4.7071 -
Local Peer NAVIDEA BIOPHARMACEUTICALS INC NYSE American 217.357 - - -285.1064 -
Local Peer LINEAGE CELL THERAPEUTICS INC NYSE American 170.765 - - 1.4576 -
Local Peer MATINAS BIOPHARMA HOLDINGS INC NYSE American 137.038 - - 4.0358 -
Local Peer CEL-SCI CORP NYSE American 132.384 - - 25.7865 -
Local Peer 22ND CENTURY GROUP INC NYSE American 104.815 - - 1.8952 -
Local Peer PALATIN TECHNOLOGIES INC NYSE American 107.848 3.015 2.918 1.1219 -
Local Peer SYNTHETIC BIOLOGICS INC NYSE American 69.228 - - 674.7500 -
Local Peer ISORAY INC NYSE American 49.119 - - 7.0633 -
Local Peer ARMATA PHARMACEUTICALS INC NYSE American 48.127 - - 2.6542 -
Local Peer IBIO INC NYSE American 24.319 - - -12.5962 -
Other Local Peers INDIA GLOBALIZATION CAPITAL INC (NYSE American), ACTINIUM PHARMACEUTICALS INC (NYSE American), NOVABAY PHARMACEUTICALS INC (NYSE American), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), AIM IMMUNOTECH INC (NYSE American)
Global Peer AMGEN INC NASDAQ 133,596.331 15.916 16.561 12.2263 2.488
Global Peer CSL ASX 141,910.746 52.894 52.894 18.9640 0.849
Global Peer GILEAD SCIENCES INC NASDAQ 81,425.054 14.927 30.236 3.9519 3.590
Global Peer AMGEN-T HKEx 594,184.000 9.032 9.399 6.9364 4.385
Global Peer VERTEX PHARMACEUTICAL NASDAQ 59,651.086 28.454 27.825 11.3548 -
Global Peer BIOGEN INC NASDAQ 50,875.622 11.483 9.429 3.6350 -
Global Peer ILLUMINA INC NASDAQ 46,199.160 55.931 47.481 10.4076 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 37,778.597 15.455 17.619 3.5965 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 27,041.754 85.575 25.249 5.6954 0.701
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 23,671.498 305.045 16.100 2.2833 -
Other Global Peers SEATTLE GENETICS INC (NASDAQ), SINO BIOPHARM (HKEx), WUXI BIO (HKEx), INCYTE CORPORATION (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BEIGENE (HKEx), EXACT SCIENCES CORP (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), 10X GENOMICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), MODERNA INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), REPLIGEN CORP (NASDAQ), BLUEBIRD BIO INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), Lonza (SGX), GENSCRIPT BIO (HKEx), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), FIBROGEN INC (NASDAQ), 3SBIO (HKEx), AGIOS PHARMACEUTICALS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), ALLOGENE THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), NATERA INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ALKERMES PLC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), UNIQURE N.V. (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), VIELA BIO INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), EPIZYME INC (NASDAQ), XENCOR INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ALECTOR INC (NASDAQ), INSMED INC (NASDAQ), ALPHAMAB-B (HKEx), REGENXBIO INC (NASDAQ), HAOHAI BIOTEC (HKEx), INTRA-CELLUAR THERAPIES INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), CORTEXYME INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), POLYNOVO LIMITED (ASX), ROCKET PHARMACEUTICALS INC (NASDAQ), NEXTCURE INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), MESOBLAST LTD (ASX), FRONTAGE (HKEx), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), CKLIFE SCIENCES (HKEx), RAPT THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), DERMIRA INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), AVITA MEDICAL LTD (ASX), XBIOTECH INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), VIVA BIOTECH (HKEx), RADIUS HEALTH INC (NASDAQ), INTREXON CORP (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), OMEROS CORP (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), CYTOKINETICS INC (NASDAQ), ASCENTAGE-B (HKEx), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), RETROPHIN INC (NASDAQ), KADMON HLDGS INC (NYSE), HOMOLOGY MEDICINES INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ARDELYX INC (NASDAQ), AVROBIO INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), KURA ONCOLOGY INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), SINOMAB BIO-B (HKEx), AGENUS INC (NASDAQ), MACROGENICS INC (NASDAQ), MERUS B V (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), VOYAGER THERAPEUTICS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), COMPUGEN (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), ASCLETIS-B (HKEx), CABALETTA BIO INC (NASDAQ), ESSEX BIO-TECH (HKEx), RIGEL PHARMACEUTICALS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), ANAPTYSBIO INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), IVERIC BIO INC (NASDAQ), PERSONALIS INC (NASDAQ), LEE'S PHARM (HKEx), MANNKIND CORPORATION (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), DPHARMA (Bursa), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), NEXT SCIENCE LTD (ASX), NOVAVAX INC (NASDAQ), GERON CORP (NASDAQ), MEDICINOVA INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), KAMADA (NASDAQ), TELIX PHARMACEUTIC (ASX), WAVE LIFE SCIENCES LTD (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), BBI LIFE SCI (HKEx), CONCERT PHARMACEUTICALS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), ATHERSYS INC (NASDAQ), IMV INC (NASDAQ), AFFIMED N V (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), XOMA CORP (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), CHIASMA INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), ARAVIVE INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), VERASTEM INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), SAVARA INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), UNI-BIO GROUP (HKEx), VTV THERAPEUTICS INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), PYC THERAPEUTICS LIMITED (ASX), AXCELLA HEALTH INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), ENZO BIOCHEM INC (NYSE), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), VACCINEX INC (NASDAQ), CHIMERIX INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), IMUGENE LIMITED (ASX), OTONOMY INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), ORGENESIS INC (NASDAQ), SESEN BIO INC (NASDAQ), EQUILLIUM INC (NASDAQ), TREVENA INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), INFLARX N V (NASDAQ), SYNLOGIC INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), INFINITY PHARMACEUTICALS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), IMMUTEP LTD (ASX), VERMILLION INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), MICROBOT MEDICAL INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), SOLIGENIX INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), ORTHOCELL LIMITED (ASX), PLURISTEM THERAPEUTICS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), CT ENTERPRISE (HKEx), SUNESIS PHARMACEUTICALS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), CURIS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), INMUNE BIO INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), RESTORBIO INC (NASDAQ), ADVAXIS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ZAFGEN INC (NASDAQ), EVOGENE LTD (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), BIOSINO BIO-TEC (HKEx), BIOCARDIA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), BIOTRON (ASX), PULMATRIX INCORPORATED (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), OCUGEN INC (NASDAQ), VAXART INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES (ASX), UNUM THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), SOPHIRIS BIO INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), AEVI GENOMIC MEDIC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), REGENT PACIFIC (HKEx), AZURRX BIOPHARMA INC (NASDAQ), ANTEOTECH LIMITED (ASX), OUTLOOK THERAPEUTICS INC (NASDAQ), BIONOMICS LTD (ASX), MEMPHASYS LTD (ASX), TALI DIGITAL LIMITED (ASX), DARE BIOSCIENCE INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ATYR PHARMA INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), EXTRAWELL PHAR (HKEx), CCP TECHNOLOGIES LTD (ASX), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), RHINOMED LIMITED (ASX), BIO-PATH HOLDINGS INC (NASDAQ), PROTEOMICS INTL LABORATORIES LTD (ASX), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), IMMURON LIMITED (ASX), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), TROVAGENE INC (NASDAQ), PRECIPIO INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), CELLMID LIMITED (ASX), DIFFUSION PHARMACEUTICALS INC (NASDAQ), PATRYS LIMITED (ASX), ENDRA LIFE SCIENCES INC (NASDAQ), Suntar Eco-City^ (SGX), HEAT BIOLOGICS INC (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), CYCLACEL PHARMA IN (NASDAQ), REGENEUS LTD (ASX), CONATUS PHARMACEUTICALS INC (NASDAQ), TOCAGEN INC (NASDAQ), BIOCEPT INC (NASDAQ), ADALTA LTD (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), SENESTECH INC (NASDAQ), SIENNA CANCER DIAGNOSTICS LTD (ASX), SENECA BIOPHARMA INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), OPGEN INC (NASDAQ), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), XENETIC BIOSCIENCES INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), LIVING CELL TECHNOLOGIES (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), HAO WEN HLDGS (HKEx), BENITEC BIOPHARMA LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), BIOXYNE LIMITED (ASX), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), MEDIBIO LIMITED (ASX), QT Vascular (SGX), PHIO PHARMACEUTICALS CORP (NASDAQ), MGRC (Bursa), SPHERIX INC (NASDAQ), TBG DIAGNOSTICS LTD (ASX), AURIS MEDICAL HOLDING LTD (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), NANOLLOSE LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), BPH ENERGY LIMITED (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.017
-3.81 %
10 Days --0.033
-7.11 %
20 Days --0.089
-17.06 %
Medium Term Return 3 Months --0.014
-3.17 %
6 Months --0.016
-3.60 %
1 Year --0.486
-52.85 %
Long Term Return 2 Years --1.746
-80.10 %
3 Years --6.366
-93.62 %
5 Years --7.166
-94.29 %
Annualised Return Annualised --
-43.60 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.350 - 0.990 Change From 1 Year Low +0.084 % Change From 1 Year Low (%) +23.94
Change From 1 Year High -0.556 % Change From 1 Year High (%) -56.18
2 Years Range 0.350 - 4.200 Change From 2 Years Low +0.084 % Change From 2 Years Low (%) +23.94
Change From 2 Years High -3.766 % Change From 2 Years High (%) -89.67
5 Years Range 0.350 - 38.700 Change From 5 Years Low +0.084 % Change From 5 Years Low (%) +23.94
Change From 5 Years High -38.266 % Change From 5 Years High (%) -98.88
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Oragenics, Inc. is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of lantibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.

Historical Price Data

Date Open High Low Close Volume VWAP
28 Jan 2020 0.440 0.456 0.430 0.434 254,682 -
27 Jan 2020 0.450 0.450 0.434 0.436 414,703 -
24 Jan 2020 0.470 0.470 0.450 0.454 481,712 -
23 Jan 2020 0.449 0.470 0.445 0.466 660,443 -
22 Jan 2020 0.460 0.460 0.430 0.451 661,390 -
21 Jan 2020 0.460 0.460 0.441 0.454 779,228 -
17 Jan 2020 0.469 0.470 0.460 0.462 464,240 -
16 Jan 2020 0.484 0.484 0.465 0.468 364,911 -
15 Jan 2020 0.472 0.479 0.463 0.467 660,053 -
14 Jan 2020 0.469 0.480 0.469 0.477 278,912 -
13 Jan 2020 0.489 0.489 0.468 0.479 435,729 -
10 Jan 2020 0.481 0.490 0.474 0.480 377,145 -
09 Jan 2020 0.493 0.495 0.470 0.474 356,840 -
08 Jan 2020 0.479 0.480 0.469 0.480 581,961 -
07 Jan 2020 0.490 0.494 0.480 0.484 297,348 -
06 Jan 2020 0.492 0.492 0.460 0.480 717,285 -
03 Jan 2020 0.485 0.501 0.480 0.486 560,601 -
02 Jan 2020 0.495 0.510 0.472 0.506 1,063,045 -
31 Dec 2019 0.520 0.530 0.516 0.523 1,162,599 -
30 Dec 2019 0.518 0.547 0.518 0.523 482,875 -
27 Dec 2019 0.535 0.540 0.510 0.527 496,616 -
26 Dec 2019 0.560 0.560 0.531 0.539 574,675 -
Summary
Current 2 Weeks
(14 Jan 2020 to 28 Jan 2020)
0.469 0.484 0.430 0.434 5,020,274 -
Previous 2 Weeks
(30 Dec 2019 to 13 Jan 2020)
0.518 0.547 0.430 0.479 6,035,428 -
4 Weeks from
(29 Nov 2019 to 27 Dec 2019)
0.615 0.620 0.430 0.527 11,698,507 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.